Approved immunotherapy drugs (multi-year total)

STO-REC-STATMBM4FPT2 National
30

United States · 2010–2025

Approved immunotherapy drugs in United States (multi-year total) stood at 30 in 2010–2025 (PhRMA).

Original source
Publisher
PhRMA
Authority tier
T2 National
Locator
Revolutionizing Cancer Care with Immunotherapy
Retrieved
17 Sep 2026
Status
Verified

What the source says

Since 2010, over 30 immunotherapy drugs have been approved to treat 25 types of cancer.

Verbatim extraction verified: The figure 30 is directly attested in the quoted passage (Revolutionizing Cancer Care with Immunotherapy).

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Cite this figure

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA
PhRMA. (2025). Research & Development. Retrieved September 17, 2026, from https://phrma.org/policy-issues/research-development. Via StatOrigin, https://statorigin.org/stat/stat_MBM4FPC6Q63D53V4H7947N7R0N
MLA
PhRMA. "Research & Development." 2025, https://phrma.org/policy-issues/research-development. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_MBM4FPC6Q63D53V4H7947N7R0N.
Chicago
PhRMA. "Research & Development." 2025. https://phrma.org/policy-issues/research-development. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_MBM4FPC6Q63D53V4H7947N7R0N.
BibTeX
@misc{phrma2025approved7n7r0n, author = {{PhRMA}}, title = {Research \& Development}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_MBM4FPC6Q63D53V4H7947N7R0N}, note = {Original source: https://phrma.org/policy-issues/research-development. Accessed September 17, 2026.} }

Provenance and verification

Everything needed to check this number yourself, without taking our word for it.

Chain of Custody · Verification Audit
Record: STO-REC-STATMBM4FP T2 National

Primary Source

Publisher
PhRMA · homepage ↗
Authority tier
Tier 2 · National Official
Report
Research & Development
Type
Press release
Published
Locator
Revolutionizing Cancer Care with Immunotherapy
Retrieved
17 September 2026
Link status
Reachable (HTTP 200)
Report licence
See source

Verification & Integrity

Audit status
Verified
Review protocol
Editorial review
Checked on
17 September 2026
Last revision
17 September 2026
Archival URI
/stat/stat_MBM4FPC6Q63D53V4H7947N7R0N